GABELLI FUNDS LLC - DEPOMED INC ownership

DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 171 filers reported holding DEPOMED INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of DEPOMED INC
ValueSharesWeighting
Q1 2018$136,000
-48.1%
20,600
-36.8%
0.00%
-50.0%
Q4 2017$262,000
+17.5%
32,600
-15.5%
0.00%
+100.0%
Q3 2017$223,000
-88.6%
38,600
-78.8%
0.00%
-91.7%
Q2 2017$1,959,000
-29.0%
182,400
-17.1%
0.01%
-25.0%
Q1 2017$2,761,000
+350.4%
220,000
+547.1%
0.02%
+300.0%
Q4 2016$613,000
+145.2%
34,000
+240.0%
0.00%
+300.0%
Q3 2016$250,000
-15.0%
10,000
-33.3%
0.00%
-50.0%
Q2 2016$294,00015,0000.00%
Other shareholders
DEPOMED INC shareholders Q2 2018
NameSharesValueWeighting ↓
DELTEC ASSET MANAGEMENT LLC 2,159,164$32,798,0007.35%
Senvest Management, LLC 4,515,935$68,597,0006.42%
Broadfin Capital, LLC 2,313,702$35,145,0003.68%
HAYS ADVISORY LLC 512,820$7,790,0001.03%
Ghost Tree Capital, LLC 120,000$1,823,0000.99%
EMERALD MUTUAL FUND ADVISERS TRUST 647,096$9,829,0000.94%
TURNER INVESTMENTS LLC 817,177$12,413,0000.74%
EMERALD ADVISERS, LLC 681,346$10,350,0000.62%
TSP Capital Management Group, LLC 86,300$1,311,0000.60%
PERKINS CAPITAL MANAGEMENT INC 38,500$585,0000.49%
View complete list of DEPOMED INC shareholders